CYCLOSPORINE
| Brand name | CEQUA |
|---|---|
| Active ingredient | CYCLOSPORINE |
| Strength | 0.09% |
| Dosage form | SOLUTION |
| Route | OPHTHALMIC |
| Modality | Small molecule |
| FDA approval | August 2018 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11951153 | February 2037 | use U-1483 |
| 10918694 | February 2037 | product |
| 8980839 | August 2033 | product |
| 9937225 | August 2033 | product |
| 10441630 | August 2033 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.